Psyence Group Inc. (CSE: PSYG)

Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST
-66.67%
Market Cap 2.10M
Revenue (ttm) n/a
Net Income (ttm) -62.46M
Shares Out 140.03M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Open 0.0150
Previous Close 0.0150
Day's Range 0.0150 - 0.0150
52-Week Range 0.0100 - 0.0800
Beta 2.05
Analysts n/a
Price Target n/a
Earnings Date Feb 26, 2025

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom. It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in... [Read more]

Sector Healthcare
Founded 2019
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PSYG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.